Gulf War Illness

Why Gulf War veterans got sick — the exposures

Gulf War veterans deployed into one of the most chemically and environmentally hazardous theaters in modern U.S. military history. Many of the exposures were not understood at the time, and no single agent explains the pattern of chronic illness reported after the war. The current presumptive framework under 38 CFR § 3.317 was built precisely because of this — Congress and VA recognized that requiring proof of which exposure caused which symptom would unfairly bar legitimate claims.

The exposure environment in the Southwest Asia theater included airborne particulates, combustion byproducts, low-dose chemical-warfare agents, prophylactic medications, vaccines, depleted uranium, pesticides, and contaminated water — often layered on top of one another over the course of a deployment.

Major exposure sources documented during Desert Shield / Desert Storm and later

• Kuwaiti oil-well fires — more than 600 wells set ablaze by retreating Iraqi forces in 1991, producing dense plumes of soot, hydrocarbons, polycyclic aromatic hydrocarbons (PAHs), heavy metals, and particulate matter that hung over the theater for nine months.
• Sarin and cyclosarin release at Khamisiyah (March 1991) — the U.S. demolition of an Iraqi ammunition depot released low-dose chemical-warfare agents downwind; DoD identified roughly 100,000 service members in the potential exposure plume.
• Pyridostigmine bromide (PB) tablets — issued to as many as 250,000 troops as nerve-agent pretreatment; long-term safety in combination with pesticides was not well studied.
• Pesticides and insect repellents — heavy use of DEET, permethrin-treated uniforms, organophosphate pesticides, and lindane around living quarters.
• Depleted uranium (DU) — armor-piercing rounds and tank armor; veterans exposed via inhalation of particles, embedded shrapnel, or contact with damaged vehicles.
• Anthrax and botulinum toxoid vaccines — administered to large numbers of troops with limited long-term safety data at the time.
• Open burn pits and diesel/JP-8 exhaust — early use of the same waste-burning practices later expanded post-9/11 (now covered by the PACT Act).
• Petroleum-contaminated water and food at forward sites; sand and silica dust exposure in austere conditions.

What § 3.317 actually presumes (in plain English)

Because no one can untangle which exposure caused which chronic symptom in a given veteran, 38 CFR § 3.317 lets qualifying Gulf War veterans claim chronic conditions without proving a specific exposure-to-disease nexus. The framework covers three buckets: undiagnosed-illness symptom clusters, medically unexplained chronic multisymptom illness (MUCMI), and a short list of infectious diseases.

For the full regulatory text, condition lists, qualifying service periods, and side-by-side comparison with the PACT Act, see the dedicated reference page.

• Complete condition list and § 3.317 vs PACT Act comparison → /gulf-war-presumptives
• Functional GI disorders (IBS, dyspepsia) deep-dive → /topics/gulf-war-functional-gi
• Burn pits and post-9/11 airborne hazards → /topics/burn-pit-exposure

Common symptom patterns reported by Gulf War veterans

The lived experience of Gulf War Illness varies widely from veteran to veteran, but several patterns appear repeatedly in the research and in VA claim files.

• Persistent fatigue that is not relieved by rest and worsens with exertion (post-exertional malaise).
• Chronic widespread muscle and joint pain without an identifiable structural cause.
• Cognitive symptoms — short-term memory problems, difficulty concentrating, word-finding trouble (often described as 'Gulf War brain fog').
• Sleep disturbance — both initiating sleep and unrefreshing sleep patterns.
• Gastrointestinal symptoms — alternating diarrhea and constipation, bloating, functional abdominal pain.
• Skin signs — rashes, dermatitis, and unexplained lesions.
• Respiratory symptoms — chronic cough, sinus complaints, and reactive airway symptoms.

How these exposures translate into a claim

1. Confirm qualifying Southwest Asia or Afghanistan service from your DD-214 and personnel file.
2. Document the chronic symptoms — duration (6+ months), frequency, severity, and impact on daily life.
3. Have a treating provider work through differential diagnosis. If no clear cause emerges, the undiagnosed-illness pathway under § 3.317(b) may apply. If a MUCMI diagnosis (fibromyalgia, CFS, IBS, functional dyspepsia) is reached, the listed-presumptive pathway under § 3.317(a)(2)(i)(B) applies.
4. File VA Form 21-526EZ identifying the symptoms or the MUCMI diagnoses. Cite § 3.317 expressly on the claim — many denials trace to reviewers evaluating the claim under direct service-connection rules instead of the presumption.
5. Add lay statements from family, coworkers, and fellow service members describing onset, persistence, and functional impact. Lay evidence is particularly persuasive for symptom-cluster claims.

Where these claims break down

• ×Trying to prove a specific exposure caused a specific symptom — § 3.317 was designed so you don't have to.
• ×Filing 'Gulf War Illness' as a single condition rather than claiming each chronic symptom cluster or MUCMI diagnosis separately.
• ×Not documenting symptom history early; chronic means symptoms persisting 6+ months.
• ×Confusing § 3.317 with the PACT Act and missing one because you assumed the other covered everything — many veterans qualify under both.
• ×Missing the December 31, 2026 manifestation deadline (subject to extension).
• ×Overlooking GWI as a basis for TDIU when the combined symptom burden prevents substantially gainful employment.

Frequently Asked Questions